Patient Anxiety About Prostate Cancer Independently Predicts Early Initiation of Androgen Deprivation Therapy for Biochemical Cancer Recurrence in Older Men: A Prospective Cohort Study

PURPOSE: Androgen deprivation therapy (ADT) is first-line therapy for patients with prostate cancer (PCA) who experience biochemical recurrence (BCR). However, the optimal timing of ADT initiation is uncertain, and earlier ADT initiation can cause toxicities that lower quality of life (QOL). We test...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Dale, William, Hemmerich, Joshua, Bylow, Kathryn, Mohile, Supriya, Mullaney, Mary, Stadler, Walter M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Clinical Oncology 2009
Soggetti:
Original Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738613/
https://ncbi.nlm.nih.gov/pubmed/19255325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.5850
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi